247 related articles for article (PubMed ID: 11310973)
21. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.
Raz S; Stark M; Assaraf YG
Drug Resist Updat; 2016 Sep; 28():43-64. PubMed ID: 27620954
[TBL] [Abstract][Full Text] [Related]
22. Folate and antifolate pharmacology.
Kamen B
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-30-S18-39. PubMed ID: 9420019
[TBL] [Abstract][Full Text] [Related]
23. Membrane transport of folates.
Matherly LH; Goldman DI
Vitam Horm; 2003; 66():403-56. PubMed ID: 12852262
[TBL] [Abstract][Full Text] [Related]
24. Carrier-mediated membrane transport of folates in mammalian cells.
Sirotnak FM; Tolner B
Annu Rev Nutr; 1999; 19():91-122. PubMed ID: 10448518
[TBL] [Abstract][Full Text] [Related]
25. The folate binding proteins.
Corrocher R; Olivieri O; Pacor ML
Haematologica; 1991; 76(6):500-4. PubMed ID: 1820987
[TBL] [Abstract][Full Text] [Related]
26. Folate transport.
Rosenberg IH; Zimmerman J; Selhub J
Chemioterapia; 1985 Oct; 4(5):354-8. PubMed ID: 3907863
[TBL] [Abstract][Full Text] [Related]
27. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption--association with epigenome stability and cancer development.
Hamid A; Wani NA; Kaur J
FEBS J; 2009 Apr; 276(8):2175-91. PubMed ID: 19292860
[TBL] [Abstract][Full Text] [Related]
28. Folate receptor endocytosis and trafficking.
Sabharanjak S; Mayor S
Adv Drug Deliv Rev; 2004 Apr; 56(8):1099-109. PubMed ID: 15094209
[TBL] [Abstract][Full Text] [Related]
29. Lack of impact of the loss of constitutive folate receptor alpha expression, achieved by RNA Interference, on the activity of the new generation antifolate pemetrexed in HeLa cells.
Chattopadhyay S; Wang Y; Zhao R; Goldman ID
Clin Cancer Res; 2004 Dec; 10(23):7986-93. PubMed ID: 15585634
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of reduced folate carrier may result in folate malabsorption across intestinal brush border membrane during experimental alcoholism.
Hamid A; Wani NA; Rana S; Vaiphei K; Mahmood A; Kaur J
FEBS J; 2007 Dec; 274(24):6317-28. PubMed ID: 18005257
[TBL] [Abstract][Full Text] [Related]
31. Folate-targeted drug strategies for the treatment of cancer.
Leamon CP
Curr Opin Investig Drugs; 2008 Dec; 9(12):1277-86. PubMed ID: 19037834
[TBL] [Abstract][Full Text] [Related]
32. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates.
Wielinga P; Hooijberg JH; Gunnarsdottir S; Kathmann I; Reid G; Zelcer N; van der Born K; de Haas M; van der Heijden I; Kaspers G; Wijnholds J; Jansen G; Peters G; Borst P
Cancer Res; 2005 May; 65(10):4425-30. PubMed ID: 15899835
[TBL] [Abstract][Full Text] [Related]
33. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
34. [Biochemical aspects of folate transport].
Totskiĭ VN; Bondarchuk NG
Usp Sovrem Biol; 1979; 88(3):353-66. PubMed ID: 395787
[No Abstract] [Full Text] [Related]
35. Folate receptors.
Antony AC
Annu Rev Nutr; 1996; 16():501-21. PubMed ID: 8839936
[TBL] [Abstract][Full Text] [Related]
36. Folate-targeted chemotherapy.
Leamon CP; Reddy JA
Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of prostaglandin A1 on membrane transport of folates mediated by both the reduced folate carrier and ATP-driven exporters.
Assaraf YG; Sierra EE; Babani S; Goldman ID
Biochem Pharmacol; 1999 Oct; 58(8):1321-7. PubMed ID: 10487535
[TBL] [Abstract][Full Text] [Related]
38. Folate receptor-targeted drugs for cancer and inflammatory diseases.
Low PS; Antony AC
Adv Drug Deliv Rev; 2004 Apr; 56(8):1055-8. PubMed ID: 15094205
[No Abstract] [Full Text] [Related]
39. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL
Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184
[TBL] [Abstract][Full Text] [Related]
40. Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.
van der Heijden JW; Oerlemans R; Dijkmans BA; Qi H; van der Laken CJ; Lems WF; Jackman AL; Kraan MC; Tak PP; Ratnam M; Jansen G
Arthritis Rheum; 2009 Jan; 60(1):12-21. PubMed ID: 19116913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
